Shanghai Huilun Pharmaceutical Co., Ltd.

上海汇伦医药股份有限公司

Pharmaceutical company in China with integrated R&D, manufacturing and commercialization, selling over ten marketed drugs including sivelestat sodium and levofolinic acid products, with a pipeline of Category I innovative drugs in immunology, pain management and oncology.

Filings

The documents are on HKEXnews; we link to the originals.

Matters the filing discloses

From the company’s latest filing; open a kind of matter to see how other companies disclosed it.

• Customer concentration
• Distribution model
• Single product, business line or region
• Pricing policy and price changes
• Outsourced production (OEM / contract manufacturing)
• Capacity and utilisation
• Reliance on the controlling shareholder
• Decline in revenue or profit
• Working capital: receivables, prepayments and cash cycle
• Inventory level and ageing